RT Journal Article
SR Electronic
T1 Dynamic Network Strategies for SARS-CoV-2 Control on a Cruise Ship
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.26.20182766
DO 10.1101/2020.08.26.20182766
A1 Jenness, Samuel M.
A1 Willebrand, Kathryn S.
A1 Malik, Amyn A.
A1 Lopman, Benjamin A.
A1 Omer, Saad B.
YR 2020
UL http://medrxiv.org/content/early/2020/10/06/2020.08.26.20182766.abstract
AB SARS-CoV-2 outbreaks have occurred on several nautical vessels, driven by the high-density contact networks on these ships. Optimal strategies for prevention and control that account for realistic contact networks are needed. We developed a network-based transmission model for SARS-CoV-2 on the Diamond Princess outbreak to characterize transmission dynamics and to estimate the epidemiological impact of outbreak control and prevention measures. This model represented the dynamic multi-layer network structure of passenger-passenger, passenger-crew, and crew-crew contacts, both before and after the large-scale network lockdown imposed on the ship in response to the disease outbreak. Model scenarios evaluated variations in the timing of the network lockdown, reduction in contact intensity within the sub-networks, and diagnosis-based case isolation on outbreak prevention. We found that only extreme restrictions in contact patterns during network lockdown and idealistic clinical response scenarios could avert a major COVID-19 outbreak. Contact network changes associated with adequate outbreak prevention were the restriction of passengers to their cabins, with limited passenger-crew contacts. Clinical response strategies required for outbreak prevention included early mass screening with an ideal PCR test (100% sensitivity) and immediate case isolation upon diagnosis. Public health restrictions on optional leisure activities like these should be considered until longer-term effective solutions such as a COVID-19 vaccine become widely available.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by National Institutes of Health grants R01 AI138783, R01 GM12428003S1, and R01 HD097175.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicable.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo primary data were used in this study. Model code is available at https://github.com/EpiModel/COVID-CruiseShip. https://github.com/EpiModel/COVID-CruiseShip